GIMBHI’s daily mental health update — 7/16/26

🤝 Spero Health acquires CleanSlate, doubling footprint and averting shutdown (Chris Larson, Behavioral Health Business) — 07/07/26
TL;DR: Spero Health acquired opioid treatment provider CleanSlate Centers—saving it from closure—doubling Spero’s footprint to 128 locations across 10 states and preserving care for nearly 20,000 patients amid a tough addiction-treatment M&A market.

🧠 Oasys Health: building AI infrastructure for behavioral healthcare (Epil Bodra, Ascendants) — 07/16/26
TL;DR: A profile of New York-based Oasys Health, which is building an AI-native operating system unifying EHR, billing, scheduling, and wearable data for behavioral health clinics, backed by its recent $4.6M raise.

🧠 AI chatbots and the erosion of therapeutic discomfort (Chantel Cohen, Psychiatric Times) — 07/14/26
TL;DR: A therapist argues that AI chatbots—now used by half of US adults—feel safe and validating but erode clients’ capacity for the productive discomfort that real therapy requires, and can’t replace human clinical judgment.

🏛️ Mirabelle Care wins early victory in legal fight for survival against Oklahoma Medicaid (Chris Larson, Behavioral Health Business) — 07/15/26
TL;DR: Autism therapy provider Mirabelle Care won a court injunction forcing Oklahoma to resume Medicaid payments it had suspended over a fraud probe tied to prior ownership, averting a shutdown that threatened care for 500 children across seven mostly rural clinics.